Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases

Detalhes bibliográficos
Autor(a) principal: Martins, Vanessa dos Santos
Data de Publicação: 2016
Outros Autores: Mori, Ana Luiza Pereira Moreira, Dorea, Egidio Lima, Pinto, Gelba Almeida, Hirata, Mario Hiroyuki, Hirata, Felipe Dominguez Crespo, Hirata, Rosario Dominguez Crespo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/128423
Resumo: Management of pharmacotherapy in elderly with metabolic diseases is challenging and potentially inappropriate medications (PIMs) are risk factors for drug interactions and adverse events. The exposure to PIMs in elderly outpatients with metabolic diseases and its relationship with polypharmacy and other variables was investigated. PIMs prescribed to 207 elderly patients (aged 60 to 96 years) with metabolic diseases who attended a University Hospital of Sao Paulo city, Brazil, from April/2010 to January/2011, were evaluated. PIMs were detected using both 2003 Beers and 2008 STOPP criteria. The association between PIMs and age, gender and polypharmacy was also examined. 2008 STOPP criteria detected more PIMs (44.4 %) than 2003 Beers criteria (16.0%, p
id USP-31_29e67e072fb367dbb1e361c9fa3a3cee
oai_identifier_str oai:revistas.usp.br:article/128423
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases Management of pharmacotherapy in elderly with metabolic diseases is challenging and potentially inappropriate medications (PIMs) are risk factors for drug interactions and adverse events. The exposure to PIMs in elderly outpatients with metabolic diseases and its relationship with polypharmacy and other variables was investigated. PIMs prescribed to 207 elderly patients (aged 60 to 96 years) with metabolic diseases who attended a University Hospital of Sao Paulo city, Brazil, from April/2010 to January/2011, were evaluated. PIMs were detected using both 2003 Beers and 2008 STOPP criteria. The association between PIMs and age, gender and polypharmacy was also examined. 2008 STOPP criteria detected more PIMs (44.4 %) than 2003 Beers criteria (16.0%, pUniversidade de São Paulo. Faculdade de Ciências Farmacêuticas2016-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/12842310.1590/s1984-82502016000400014Brazilian Journal of Pharmaceutical Sciences; Vol. 52 Núm. 4 (2016); 699-707Brazilian Journal of Pharmaceutical Sciences; v. 52 n. 4 (2016); 699-707Brazilian Journal of Pharmaceutical Sciences; Vol. 52 No. 4 (2016); 699-7072175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/128423/125275Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)info:eu-repo/semantics/openAccessMartins, Vanessa dos SantosMori, Ana Luiza Pereira MoreiraDorea, Egidio LimaPinto, Gelba AlmeidaHirata, Mario HiroyukiHirata, Felipe Dominguez CrespoHirata, Rosario Dominguez Crespo2017-03-16T18:09:44Zoai:revistas.usp.br:article/128423Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2017-03-16T18:09:44Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases
title Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases
spellingShingle Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases
Martins, Vanessa dos Santos
title_short Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases
title_full Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases
title_fullStr Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases
title_full_unstemmed Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases
title_sort Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases
author Martins, Vanessa dos Santos
author_facet Martins, Vanessa dos Santos
Mori, Ana Luiza Pereira Moreira
Dorea, Egidio Lima
Pinto, Gelba Almeida
Hirata, Mario Hiroyuki
Hirata, Felipe Dominguez Crespo
Hirata, Rosario Dominguez Crespo
author_role author
author2 Mori, Ana Luiza Pereira Moreira
Dorea, Egidio Lima
Pinto, Gelba Almeida
Hirata, Mario Hiroyuki
Hirata, Felipe Dominguez Crespo
Hirata, Rosario Dominguez Crespo
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Martins, Vanessa dos Santos
Mori, Ana Luiza Pereira Moreira
Dorea, Egidio Lima
Pinto, Gelba Almeida
Hirata, Mario Hiroyuki
Hirata, Felipe Dominguez Crespo
Hirata, Rosario Dominguez Crespo
description Management of pharmacotherapy in elderly with metabolic diseases is challenging and potentially inappropriate medications (PIMs) are risk factors for drug interactions and adverse events. The exposure to PIMs in elderly outpatients with metabolic diseases and its relationship with polypharmacy and other variables was investigated. PIMs prescribed to 207 elderly patients (aged 60 to 96 years) with metabolic diseases who attended a University Hospital of Sao Paulo city, Brazil, from April/2010 to January/2011, were evaluated. PIMs were detected using both 2003 Beers and 2008 STOPP criteria. The association between PIMs and age, gender and polypharmacy was also examined. 2008 STOPP criteria detected more PIMs (44.4 %) than 2003 Beers criteria (16.0%, p
publishDate 2016
dc.date.none.fl_str_mv 2016-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/128423
10.1590/s1984-82502016000400014
url https://www.revistas.usp.br/bjps/article/view/128423
identifier_str_mv 10.1590/s1984-82502016000400014
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/128423/125275
dc.rights.driver.fl_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 52 Núm. 4 (2016); 699-707
Brazilian Journal of Pharmaceutical Sciences; v. 52 n. 4 (2016); 699-707
Brazilian Journal of Pharmaceutical Sciences; Vol. 52 No. 4 (2016); 699-707
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222912872972288